Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
CSRNP1	"AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1"	ENSG00000144655	"Cysteine and serine rich nuclear protein 1"	Q96S65	3	39141855-39154562	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045207, HPA058463"			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA045207: AB_10967202, HPA058463: "	"unprognostic (2.90e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (1.07e-4)"	"prognostic unfavourable (6.47e-4)"	"unprognostic (2.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	33.5	24.9	5.9	16.4	11.5	70.1	20.4	4.9	8.6	16.2	14.4	11.4	13.9	5.1	12.9	9.6	25.9	35.8	28.7	19.7	5.4	5.3	9.6	33.3	35.7	7.9	8.8	3.3	24.9	16.3	11.7	17.6	30.9	15.3	15.8	6.8	9.7	10.9	50.1	22.4	19.9	21.0	26.9	11.9	9.2	20.3	11.4	7.5	8.9	14.5	14.6	7.8	21.4	16.9	3.6	3.9	15.9	9.2	2.2	2.5	1.9	2.3	5.2	1.3	2.6	2.6	2.8	4.3	8.6	12.0	7.2	5.9	7.3	2.1	7.7	1.8	6.5	2.6	1.6	11.3	3.5	11.4	2.1	8.7	4.2	5.5	3.3	2.1	8.7	1.3	6.2	11.2	1.8	9.7	6.6	13.6	5.8	7.4	0.4	3.5	6.2	4.4	3.6	5.7	12.5	5.7	8.5	3.8	0.6	4.7	35.4	2.9	3.9	4.0	4.8	3.7	15.7	3.1	6.3	3.5	2.9	3.5	8.0	2.7	4.6	0.1	2.7	3.2	1.7	5.6	2.1	3.6	1.6	1.9	3.0	3.6	2.0	1.3	15.9	2.2	9.2	3.9	2.5	1.9	5.9	11.5	4.9	8.6	5.4	5.3	8.8	3.3	15.3	7.5
CSRNP2	"C12ORF2, C12orf22, FAM130A1, PPP1R72, TAIP-12"	ENSG00000110925	"Cysteine and serine rich nuclear protein 2"	Q9H175	12	51061205-51083664	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018503, HPA019914"	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA018503: AB_1845535, HPA019914: "	"unprognostic (8.67e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavourable (6.51e-4)"	"unprognostic (1.10e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.74e-2)"	"prognostic favourable (2.78e-4)"	13.7	12.3	14.7	8.0	16.5	3.5	22.2	23.3	26.4	13.3	9.2	11.4	6.0	7.6	16.1	14.2	9.0	9.6	13.3	11.8	14.0	16.2	10.4	7.9	9.7	9.3	12.7	13.5	14.7	10.4	11.2	15.7	12.8	13.3	11.3	8.2	11.7	8.6	12.8	15.8	8.9	7.1	16.7	11.4	9.6	8.3	32.1	12.8	12.1	13.0	8.3	7.7	11.2	9.0	1.2	0.9	2.6	0.9	5.9	2.7	0.4	5.7	6.4	19.4	17.3	14.9	10.6	20.6	11.2	12.6	15.4	10.6	12.2	4.1	4.7	11.0	11.7	6.9	9.4	6.0	12.2	10.2	7.1	5.6	7.2	3.7	16.3	3.7	8.5	12.9	17.0	17.7	10.2	15.0	7.8	8.4	17.6	9.6	13.1	5.3	16.0	10.0	8.0	12.6	3.7	8.7	7.3	13.7	16.3	16.3	12.8	16.2	8.1	10.6	13.6	15.3	8.2	10.2	7.6	9.1	10.1	4.4	9.4	5.1	4.9	0.0	0.9	2.3	1.9	0.1	0.7	1.2	2.0	1.1	0.9	0.7	2.0	2.7	2.6	5.9	0.6	0.4	1.3	0.4	14.7	16.5	23.3	23.2	14.0	16.2	12.7	13.5	13.3	12.8
CSRNP3	"FAM130A2, FLJ32093, PPP1R73, TAIP-2"	ENSG00000178662	"Cysteine and serine rich nuclear protein 3"	Q8WYN3	2	165469647-165689407	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.7;pituitary gland: 21.1"	"Cell line enhanced"	"Detected in some"		"AF22: 12.7;PC-3: 3.1;SCLC-21H: 9.3;SH-SY5Y: 7.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017905	Supported		Uncertain	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA017905: AB_1857757"	"unprognostic (2.85e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.08e-2)"	2.1	5.5	9.3	1.4	24.9	0.7	6.7	8.8	31.7	5.7	2.0	3.2	0.4	2.1	6.3	2.3	2.0	2.5	2.5	3.4	9.3	10.2	3.7	1.8	1.4	1.1	5.3	13.2	7.8	8.0	6.0	21.1	1.1	7.8	3.9	2.5	4.0	4.9	5.1	0.9	2.1	1.7	5.7	2.9	2.1	2.0	1.9	4.8	0.0	5.3	0.0	1.0	1.9	2.5	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.0	0.4	0.2	0.6	0.0	0.0	0.9	0.6	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.7	0.7	0.0	9.3	7.6	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.3	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	24.9	8.8	31.7	9.3	10.2	5.3	13.2	7.8	4.8
LRRFIP1	"FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP"	ENSG00000124831	"LRR binding FLII interacting protein 1"	Q32MZ4	2	237627576-237813682	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA006979	Approved		Supported	Cytosol			120000	Cytosol		"HPA006979: AB_1079282"	"unprognostic (2.07e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.99e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.64e-2)"	27.2	9.9	11.2	28.6	9.4	28.5	31.3	8.8	14.5	28.0	30.9	5.4	16.4	13.7	36.3	24.1	30.1	18.5	23.3	30.7	11.1	12.0	32.1	27.6	29.9	25.5	7.7	10.0	18.0	10.4	31.3	14.2	16.8	12.2	27.5	16.3	8.2	20.2	14.4	52.7	12.6	19.8	56.8	7.4	27.9	21.5	7.3	5.8	27.6	19.0	23.1	19.4	49.3	39.5	12.8	17.6	71.6	33.1	9.3	19.9	10.6	22.2	11.5	5.5	11.1	7.9	15.7	18.5	16.8	16.1	9.1	9.1	4.4	15.0	1.9	6.7	25.8	18.7	12.6	23.2	19.5	72.9	8.2	17.7	13.1	12.4	15.9	23.3	16.9	7.0	48.8	21.1	51.9	18.4	13.0	18.3	19.5	10.8	13.5	17.8	7.2	10.6	20.1	32.3	18.1	29.1	32.6	11.3	7.5	7.8	17.9	21.2	10.1	29.4	32.2	11.0	10.7	11.8	17.6	3.7	3.1	12.5	16.0	23.6	12.0	14.3	22.8	49.4	16.5	19.7	12.4	11.0	19.9	17.1	17.6	12.8	10.6	11.8	71.6	9.3	33.1	15.5	15.3	10.6	11.2	9.4	8.8	14.5	11.1	12.0	7.7	10.0	12.2	5.8
LRRFIP2	HUFI-2	ENSG00000093167	"LRR binding FLII interacting protein 2"	Q9Y608	3	37052656-37183689	"Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035956, HPA042023"	Uncertain		Approved	"Plasma membrane,Actin filaments"			1000000	"Plasma membrane, Actin filaments"		"HPA035956: AB_10671238, HPA042023: "	"unprognostic (2.03e-3)"	"prognostic favourable (6.31e-4)"	"unprognostic (1.16e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.84e-3)"	"unprognostic (3.76e-2)"	15.4	17.3	23.0	17.5	22.0	27.5	21.9	30.0	22.8	35.7	35.8	26.5	17.7	24.7	28.2	20.0	33.0	15.7	22.8	47.4	23.8	25.3	19.8	33.9	18.7	19.3	24.2	19.4	20.6	16.9	33.9	18.3	16.9	24.4	30.3	24.8	19.6	19.3	19.5	58.5	23.2	37.1	27.3	31.2	29.7	17.0	47.2	24.8	11.6	20.6	33.6	21.6	23.7	25.1	7.1	9.8	22.7	17.2	11.9	8.8	7.5	15.3	8.6	9.9	7.8	13.3	20.4	8.7	41.9	41.8	23.7	27.2	8.0	7.1	6.1	6.9	40.4	8.0	7.2	20.7	38.8	13.5	5.7	10.9	12.2	7.8	19.0	8.6	6.6	9.0	14.9	30.8	31.9	16.3	8.6	10.7	19.6	3.9	7.3	4.6	6.5	11.0	3.5	28.3	6.1	16.6	6.0	3.6	5.7	16.2	15.0	13.5	8.6	8.9	15.7	18.2	12.2	26.6	19.7	8.3	14.9	9.3	10.7	7.7	25.7	12.2	15.0	22.7	6.6	10.4	8.5	7.1	7.0	7.0	9.8	5.4	5.2	6.2	14.0	11.9	17.2	5.5	8.8	7.5	23.0	22.0	30.0	22.8	23.8	25.3	24.2	19.4	24.4	24.8
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290511-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA056310: , HPA061382: , HPA073519: "	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favourable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	23.7	19.8	17.6	17.8	26.3	22.5	24.1	33.0	26.7	19.2	24.4	24.7	18.0	19.2	26.3	19.2	22.3	18.6	14.4	26.4	16.2	16.0	17.4	31.3	19.6	23.1	17.8	19.5	26.5	20.9	28.3	30.9	17.7	25.2	20.4	22.4	19.3	22.9	23.6	44.8	31.2	23.0	21.5	18.1	21.0	19.3	14.4	22.0	35.1	26.7	19.1	32.8	24.7	19.8	10.7	12.3	22.9	7.1	6.8	10.1	5.0	15.0	12.3	11.3	10.7	16.9	19.0	11.4	14.2	14.3	16.1	16.2	11.1	6.2	23.4	9.1	16.4	8.5	20.1	15.4	15.2	17.0	10.1	12.3	30.0	12.4	20.6	21.8	13.6	17.7	25.8	13.8	34.8	9.8	18.6	20.4	16.8	10.6	14.0	20.5	18.3	13.9	15.1	12.3	12.7	10.9	14.5	15.7	11.0	14.2	15.3	8.1	8.9	21.8	12.3	13.2	11.1	9.5	15.4	11.0	9.9	23.2	14.5	11.0	7.5	22.9	4.2	7.9	8.4	7.1	8.9	10.7	9.0	9.0	7.1	9.1	10.1	9.9	3.0	6.8	5.5	12.3	6.1	5.0	17.6	26.3	33.0	26.7	16.2	16.0	17.8	19.5	25.2	22.0
NFXL1	HOZFP	ENSG00000170448	"Nuclear transcription factor, X-box binding like 1"	Q6ZNB6	4	47847233-47914667	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059132	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA059132: "	"unprognostic (5.37e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (1.13e-2)"	"unprognostic (6.26e-3)"	"unprognostic (8.48e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (4.72e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.01e-2)"	8.3	5.8	7.8	7.2	8.7	6.5	10.8	19.1	9.4	10.1	7.4	6.2	12.2	7.8	13.3	19.2	9.7	9.6	6.9	5.5	6.7	5.5	7.4	9.5	7.4	6.5	7.0	9.6	10.9	12.8	11.9	19.6	8.7	7.6	9.0	8.6	5.3	12.4	10.2	7.1	9.3	7.4	8.8	8.8	7.5	8.2	21.3	7.0	5.9	17.2	4.4	7.7	9.2	10.9	2.5	1.9	5.6	2.3	1.5	3.5	1.7	5.4	3.5	3.9	8.0	7.3	12.2	13.2	3.7	5.3	6.1	7.6	5.8	12.5	4.3	7.2	2.5	5.6	9.9	7.5	7.3	3.3	3.9	4.7	6.4	10.6	9.6	11.3	9.4	7.9	10.0	4.2	25.2	5.3	8.3	5.4	6.3	5.2	8.9	5.4	9.3	5.4	8.0	7.5	7.2	7.8	10.4	12.3	5.9	2.8	7.9	5.4	5.5	3.3	4.3	8.0	5.1	3.7	8.3	8.8	5.3	8.8	4.7	6.4	7.0	0.0	1.7	1.7	2.3	2.3	2.8	2.2	3.2	2.5	1.6	2.5	3.5	3.4	5.6	1.5	1.1	1.9	2.0	1.7	7.8	8.7	19.1	9.4	6.7	5.5	7.0	9.6	7.6	7.0
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71283192-71301168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"			150000	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	37.2	55.9	30.2	37.7	30.8	51.2	37.2	54.8	38.6	45.4	33.4	36.0	38.4	29.9	52.4	40.5	41.0	40.5	37.2	30.5	27.5	29.0	40.1	43.3	37.3	45.7	28.8	31.7	69.2	61.0	39.4	48.2	42.4	27.5	40.8	37.5	42.5	39.8	41.4	37.2	38.4	35.2	40.5	38.3	45.9	40.3	34.4	29.0	98.4	51.0	39.1	57.4	43.6	36.8	44.1	47.3	35.3	51.8	45.4	51.8	58.9	58.5	64.8	89.7	49.2	36.6	37.8	49.1	48.0	44.7	65.0	57.4	51.4	43.5	66.6	53.5	44.2	43.8	133.8	41.7	71.6	50.7	89.4	54.6	68.0	51.1	31.0	76.6	48.0	40.0	29.8	65.7	44.1	53.3	69.6	69.9	59.9	52.0	99.0	69.8	111.6	52.6	89.1	94.0	57.1	49.8	51.8	62.3	77.3	62.2	40.6	55.1	38.2	49.6	48.9	42.1	63.2	58.8	55.5	40.3	76.3	75.8	31.4	89.1	60.1	35.3	44.8	34.9	45.8	47.6	51.8	43.7	46.6	44.9	47.3	44.1	50.8	50.2	20.8	45.4	51.8	41.2	50.1	58.9	30.2	30.8	54.8	38.6	27.5	29.0	28.8	31.7	27.5	29.0
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611714-129757082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	14.8	7.3	10.9	18.9	13.0	20.3	18.2	22.2	11.1	15.4	10.3	12.6	16.0	9.0	15.7	10.4	10.1	18.7	10.0	12.3	11.5	11.1	10.0	7.8	11.2	18.7	12.1	7.7	24.4	15.2	13.5	10.9	12.5	11.5	11.5	9.9	11.7	13.8	13.9	19.3	12.2	10.7	14.0	9.6	14.2	8.7	17.2	15.2	29.2	13.8	11.4	16.1	12.8	19.2	8.8	7.0	13.1	7.0	5.8	13.3	6.2	11.6	9.6	13.8	12.2	8.4	6.7	11.0	8.1	8.5	12.5	9.8	11.6	7.8	13.4	6.0	9.2	8.9	14.9	8.2	12.8	12.8	10.6	11.1	8.1	7.8	6.1	13.5	11.1	5.7	7.8	12.3	11.9	9.2	13.4	10.4	7.6	10.6	26.5	12.8	12.9	8.5	17.0	11.2	11.9	7.1	8.5	12.0	13.1	12.3	12.8	8.2	7.9	13.0	7.0	7.1	9.8	8.2	14.9	11.3	11.2	23.8	7.5	12.6	13.6	6.1	5.5	13.1	11.4	6.9	13.3	7.7	8.7	10.5	7.0	8.8	9.6	8.2	11.4	5.8	7.0	4.7	9.1	6.2	10.9	13.0	22.2	11.1	11.5	11.1	12.1	7.7	11.5	15.2
PHF5A	"bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7"	ENSG00000100410	"PHD finger protein 5A"	Q7RTV0	22	41459717-41468725	"Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028885	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA028885: AB_10602079"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (3.02e-8)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.91e-2)"	24.5	20.8	21.4	21.4	24.9	47.6	27.8	21.3	27.3	20.7	24.0	27.6	18.2	22.0	24.4	26.8	28.8	22.2	21.9	18.3	22.0	20.8	26.1	28.9	20.0	30.9	32.4	23.8	21.9	25.9	18.1	24.5	29.7	23.0	20.1	29.0	21.5	22.4	20.0	32.4	25.3	26.9	22.3	29.5	27.1	24.8	27.3	28.8	38.0	23.4	30.4	38.4	21.3	22.8	33.8	34.2	39.5	33.5	30.4	35.0	40.0	22.9	16.7	28.6	18.8	21.1	16.0	19.8	23.6	19.2	30.8	26.2	22.6	13.7	33.3	13.8	17.4	17.9	38.6	27.9	35.0	20.5	40.2	20.7	25.2	26.2	22.1	54.0	16.5	15.4	21.8	24.3	30.5	21.8	27.5	21.4	22.1	30.7	43.6	36.0	28.6	24.6	33.2	25.4	23.3	20.3	18.3	14.1	11.8	25.8	17.1	25.4	13.7	28.2	14.8	16.5	28.9	13.2	28.2	17.7	31.0	56.0	15.9	23.7	17.5	21.4	33.5	38.9	27.0	30.8	35.0	33.8	31.2	33.6	34.2	30.4	30.9	30.1	39.5	30.4	28.4	28.8	32.5	40.0	21.4	24.9	21.3	27.3	22.0	20.8	32.4	23.8	23.0	28.8
PSPC1	"FLJ10955, PSP1"	ENSG00000121390	"Paraspeckle component 1"	Q8WXF1	13	19674752-19783019	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038904	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA038904: AB_10673291"	"unprognostic (2.13e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (1.13e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.69e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.61e-2)"	"prognostic favourable (1.46e-4)"	"unprognostic (7.72e-2)"	10.6	14.6	17.8	14.1	18.7	45.0	16.8	24.6	24.7	13.9	15.0	15.3	11.7	12.6	16.0	23.3	15.6	17.1	12.8	11.4	18.9	19.8	13.1	9.2	10.2	19.0	14.6	18.4	16.3	11.2	8.4	23.6	25.7	15.9	11.9	16.4	17.6	11.4	9.4	20.3	14.7	13.1	15.0	12.2	13.8	12.3	23.9	13.6	27.5	12.9	10.7	21.2	12.3	10.9	18.2	17.8	14.8	18.7	9.6	18.2	12.1	18.2	7.6	17.9	8.9	7.4	7.9	23.3	9.8	13.0	18.7	17.0	25.2	10.6	24.4	10.6	10.4	9.3	20.7	11.9	19.6	10.5	10.2	28.0	5.5	30.6	14.5	20.1	18.0	12.1	2.5	11.3	12.7	15.8	15.2	10.1	16.3	19.9	23.5	19.6	25.1	10.1	16.2	17.9	12.7	19.2	27.8	16.5	8.5	13.4	22.7	8.6	13.2	21.2	9.3	11.3	10.8	10.7	9.4	8.7	5.1	42.2	5.1	12.1	13.4	10.6	18.1	11.0	10.2	18.7	11.1	18.2	13.7	9.4	16.6	18.0	13.8	10.4	14.8	9.6	13.5	17.8	18.2	12.1	17.8	18.7	24.6	24.7	18.9	19.8	14.6	18.4	15.9	13.6
PURA	"PUR-ALPHA, PUR1, PURALPHA"	ENSG00000185129	"Purine rich element binding protein A"	Q00577	5	140107777-140125619	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														150000				"unprognostic (2.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.28e-2)"	"prognostic favourable (4.77e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.09e-1)"	10.5	14.4	13.9	9.0	20.3	2.0	10.4	23.4	21.4	15.9	17.3	13.0	13.7	11.8	12.6	10.8	13.6	10.5	10.9	12.3	14.2	12.2	18.8	13.7	9.5	8.8	16.6	10.2	16.2	10.7	30.9	14.8	12.0	14.4	17.0	8.3	11.7	12.4	14.8	14.6	11.2	26.0	17.9	14.6	15.1	10.6	7.5	18.8	10.4	19.4	6.2	9.5	17.1	18.5	3.0	1.8	3.3	1.4	3.7	3.7	0.8	6.9	3.1	2.4	10.5	9.9	14.3	6.8	13.7	8.7	7.7	7.1	8.1	6.4	8.9	12.0	9.7	5.6	8.0	10.4	12.4	9.0	10.1	5.9	6.1	3.1	5.4	5.3	7.0	5.7	8.6	8.0	8.0	3.8	5.2	6.8	7.0	5.8	7.1	6.0	1.8	6.9	6.1	9.1	5.3	7.6	5.6	6.1	5.2	8.2	8.6	9.8	7.0	7.7	11.2	13.7	5.1	4.0	10.1	9.5	5.1	7.0	7.4	6.5	10.5	3.3	1.4	2.2	2.6	0.9	2.4	2.2	2.8	2.6	1.2	3.0	2.6	3.7	0.7	3.7	1.2	1.8	2.2	0.8	13.9	20.3	23.4	14.3	14.2	12.2	16.6	10.2	14.4	18.8
PURB	PURBETA	ENSG00000146676	"Purine rich element binding protein B"	Q96QR8	7	44876293-44885361	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048766			Supported	Nucleoplasm			13000	Nucleoplasm		"HPA048766: "	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.49e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.22e-2)"	12.1	9.6	19.1	12.0	20.3	13.5	14.2	30.8	22.0	13.7	14.2	11.1	6.6	8.7	13.1	9.4	13.9	11.6	11.6	9.1	18.5	9.2	11.3	10.0	12.4	11.1	15.6	13.4	12.5	10.1	17.4	10.4	15.4	12.9	12.8	9.0	11.0	11.3	11.6	14.3	16.7	10.7	18.5	12.4	10.8	10.8	7.8	15.0	12.3	13.9	7.8	11.9	11.7	11.8	1.5	1.6	3.3	1.2	1.5	2.0	0.6	8.8	5.0	9.0	16.9	8.4	13.4	6.0	12.3	9.7	9.3	9.0	7.5	7.0	13.4	10.8	14.2	16.5	8.4	10.9	18.5	10.8	6.8	6.7	12.3	4.2	8.4	10.5	10.7	11.0	14.0	17.7	13.0	9.8	11.7	12.6	19.4	12.3	8.7	13.2	14.0	8.8	7.2	27.3	8.7	7.7	15.4	8.9	12.7	12.3	25.7	7.6	17.2	12.0	16.5	16.3	17.9	10.6	20.7	22.1	19.3	4.3	12.2	12.3	21.6	1.6	1.2	1.7	1.9	1.1	2.0	0.9	1.6	1.5	0.6	1.5	1.5	1.7	3.3	1.5	0.9	1.6	1.2	0.6	19.1	20.3	30.8	22.0	18.5	9.2	15.6	13.4	12.9	15.0
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7"	"Cell line enhanced"	"Detected in some"		"AF22: 8.8;HEK 293: 4.4;HUVEC TERT2: 4.3;NTERA-2: 6.9;SH-SY5Y: 8.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: "	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	1.3	1.9	11.0	1.2	10.3	0.6	0.9	14.7	13.5	2.4	1.0	2.4	0.5	1.0	5.6	2.6	1.5	1.6	3.0	1.6	9.4	6.2	1.7	0.7	1.4	1.3	4.9	7.3	1.6	0.7	0.6	3.9	1.5	6.2	1.9	1.1	1.7	1.6	2.6	1.0	0.9	1.0	5.0	4.5	2.5	1.3	8.1	6.4	0.0	0.8	0.0	1.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.1	0.0	0.0	0.2	0.4	0.7	1.8	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	1.1	0.0	4.4	1.6	0.0	0.2	0.0	0.0	0.2	1.3	0.0	1.3	0.0	4.3	0.4	0.5	0.2	0.0	0.9	0.0	6.9	0.3	2.2	1.2	0.0	0.0	0.0	1.2	8.3	0.0	0.0	0.0	0.0	0.0	2.7	3.0	3.7	0.0	0.4	0.3	0.0	0.2	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	10.3	14.7	8.9	9.4	6.2	4.9	7.3	6.2	6.4
RFXANK	"ANKRA1, BLS, F14150_1, MGC138628, RFX-B"	ENSG00000064490	"Regulatory factor X associated ankyrin containing protein"	O14593	19	19192229-19201869	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049157, HPA053330"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA049157: , HPA053330: "	"unprognostic (3.16e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.04e-3)"	16.2	11.0	15.8	19.5	17.8	28.4	15.6	7.6	15.3	19.5	20.1	14.9	17.4	16.9	16.6	20.3	21.8	25.3	12.8	17.7	14.3	12.7	19.0	11.3	14.3	22.5	16.0	10.1	18.8	17.9	12.2	14.0	21.9	13.6	17.7	9.0	16.1	27.0	22.4	32.0	18.7	15.3	11.9	13.0	26.5	16.7	8.5	9.3	49.6	36.6	21.8	23.4	15.1	13.8	25.1	31.7	28.4	18.2	18.3	23.3	15.7	18.4	11.6	8.3	16.5	2.9	8.1	20.7	9.2	9.7	15.9	15.8	9.6	38.8	18.2	23.7	9.5	13.8	7.0	18.2	7.1	12.5	11.0	14.5	11.8	14.0	30.3	20.6	30.8	15.5	10.8	13.9	10.2	15.8	28.8	20.8	8.6	37.1	26.8	27.4	9.9	26.4	22.8	8.4	31.7	13.1	13.0	6.8	14.3	9.6	12.3	22.6	17.8	42.2	15.4	8.7	9.2	20.5	14.8	24.1	26.0	27.0	12.6	25.7	16.5	20.5	17.7	28.4	15.1	18.2	12.6	23.6	16.9	16.3	20.0	25.1	17.1	16.5	7.6	18.3	13.3	31.7	23.3	15.7	15.8	17.8	7.6	15.3	14.3	12.7	16.0	10.1	13.6	9.3
RFXAP		ENSG00000133111	"Regulatory factor X associated protein"	O00287	13	36819224-36829104	"Disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	SCID	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032035			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA032035: "	"unprognostic (2.03e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.14e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.15e-2)"	"prognostic favourable (2.26e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.94e-1)"	"prognostic favourable (4.18e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (2.81e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.99e-3)"	8.5	6.7	15.0	8.8	14.4	9.2	9.0	31.8	15.6	12.7	9.5	12.3	8.4	5.7	13.1	10.2	5.8	10.9	7.7	6.4	13.0	9.1	6.2	5.0	8.1	11.5	13.3	10.8	13.9	9.3	11.9	14.2	7.0	11.3	10.3	8.1	9.8	8.8	11.3	8.1	6.5	8.7	11.1	10.5	9.1	7.9	11.7	14.5	19.7	11.2	4.6	9.8	8.0	8.1	1.4	1.9	2.4	0.6	0.7	1.3	0.0	4.5	1.1	6.6	9.2	2.5	3.4	4.2	3.6	3.9	6.9	4.3	3.2	3.7	19.8	3.1	3.3	4.2	6.8	2.2	7.9	14.8	11.3	9.5	5.0	6.2	4.5	17.3	7.0	3.1	4.1	3.4	2.6	5.2	5.4	4.0	2.1	2.2	17.3	12.4	7.0	2.0	15.2	12.3	5.9	2.9	2.8	5.4	6.8	3.6	2.4	2.8	2.4	10.4	4.0	1.8	3.9	6.2	3.3	3.8	3.1	15.0	5.1	12.1	2.8	0.0	0.1	2.4	1.0	0.0	0.8	1.4	0.6	1.1	0.1	0.5	0.7	1.3	0.0	0.7	0.6	1.9	1.1	0.0	15.0	14.4	31.8	15.6	13.0	9.1	13.3	10.8	11.3	14.5
SFPQ	"PPP1R140, PSF"	ENSG00000116560	"Splicing factor proline and glutamine rich"	P23246	1	35176378-35193148	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009886, HPA047513, HPA054689"	Enhanced		Enhanced	Nucleoplasm			280000	Nucleoplasm		"CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574"	"prognostic favourable (9.56e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (7.91e-13)"	"unprognostic (3.10e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.77e-3)"	40.5	35.7	31.5	39.4	31.4	122.5	48.3	53.0	38.5	39.0	31.4	37.8	32.9	30.0	45.3	36.5	45.5	43.0	28.1	34.0	29.1	24.6	36.4	34.2	47.6	48.8	26.3	32.6	59.9	40.2	45.8	46.3	35.5	31.9	35.5	38.0	35.7	39.6	38.0	44.9	42.9	34.1	36.5	32.8	42.4	35.5	37.5	32.9	95.2	35.3	24.1	60.6	35.9	38.6	6.9	11.2	4.4	8.8	4.9	8.9	3.3	36.1	30.2	52.8	29.8	13.0	19.6	49.6	19.8	20.2	33.9	24.8	32.9	26.2	66.1	27.6	22.9	33.1	57.4	38.8	46.3	35.2	38.1	49.7	32.6	39.0	17.6	51.6	29.6	15.6	15.1	29.4	14.3	29.5	56.1	31.6	32.9	31.5	60.4	44.3	62.9	29.3	61.4	35.9	43.0	32.7	44.0	38.1	42.4	28.6	22.3	28.7	26.1	36.8	31.3	27.2	40.0	17.8	42.4	36.2	30.7	67.3	19.4	34.2	38.6	2.6	6.5	4.4	7.7	8.8	8.9	6.2	7.6	6.1	5.8	6.9	7.2	7.9	3.4	4.9	6.4	11.2	8.2	3.3	31.5	31.4	53.0	38.5	29.1	24.6	26.3	32.6	31.9	32.9
TCF25	"KIAA1049, Nulp1"	ENSG00000141002	"Transcription factor 25"	Q9BQ70	16	89873570-89913627	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041699, HPA041786"	Enhanced									"HPA041699: AB_10960254, HPA041786: AB_10960526"	"unprognostic (1.33e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (6.95e-4)"	"unprognostic (6.67e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.08e-1)"	42.4	52.8	46.6	45.6	60.3	69.6	40.6	53.9	77.3	41.1	43.4	41.9	48.3	50.3	47.7	41.4	45.6	48.4	49.2	47.2	41.2	48.0	39.4	49.3	38.6	45.7	42.6	58.1	58.1	57.1	55.5	52.3	66.2	54.7	40.5	31.3	41.5	50.3	49.6	50.8	48.6	44.9	45.2	38.3	46.2	47.1	62.5	40.8	30.9	58.9	29.8	42.8	45.1	37.5	29.0	41.9	66.4	38.9	22.2	30.0	20.4	15.2	22.7	25.2	33.6	20.8	22.6	28.3	37.7	28.3	28.6	13.4	14.6	23.5	36.2	30.1	26.9	15.7	14.1	16.4	11.6	15.1	30.1	18.4	21.8	28.2	35.0	21.4	25.3	27.2	17.0	17.7	19.3	25.4	33.4	22.3	29.4	50.2	23.3	41.2	16.2	12.6	37.0	24.2	20.5	24.3	21.4	22.7	14.0	57.1	21.6	20.5	21.1	22.4	38.9	24.2	25.9	13.6	15.8	28.7	9.8	20.5	23.5	25.3	30.5	26.9	38.9	29.6	30.0	30.9	22.4	21.1	22.2	23.3	26.5	29.0	19.2	19.9	66.4	22.2	27.8	41.9	18.8	20.4	46.6	60.3	53.9	77.3	41.2	48.0	42.6	58.1	54.7	40.8
ZNFX1	"FLJ11277, KIAA1404"	ENSG00000124201	"Zinc finger NFX1-type containing 1"	Q9P2E3	20	49237946-49278426	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046629	Approved		Approved	Mitochondria				Mitochondria		"HPA046629: AB_2616451"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.71e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.86e-2)"	27.2	14.9	13.2	21.5	15.1	32.8	19.3	14.4	19.7	16.6	16.0	20.1	12.1	14.5	21.3	17.4	13.1	17.2	19.2	16.5	12.3	12.0	16.5	13.4	28.2	20.5	13.4	13.8	18.3	12.2	23.8	14.6	17.4	17.1	15.5	14.4	21.1	14.4	13.7	23.0	17.6	20.6	18.3	14.4	25.9	16.2	23.9	14.6	18.6	21.4	14.4	22.7	16.8	15.0	5.7	5.1	30.0	14.0	5.6	8.3	5.4	5.7	9.0	2.1	3.0	11.9	9.4	3.7	7.9	18.6	49.5	20.7	10.2	4.8	4.8	10.2	15.6	11.2	4.0	10.7	17.2	4.5	1.3	5.7	6.5	4.5	10.3	4.6	7.0	9.9	10.0	11.0	8.2	7.4	4.3	6.0	12.3	2.4	4.9	3.1	2.0	7.5	3.1	7.3	1.3	8.1	8.0	2.2	1.6	11.6	22.7	8.1	5.8	3.9	18.5	24.3	6.9	8.8	7.6	4.0	1.4	2.6	9.8	3.1	5.3	8.8	6.7	10.8	8.3	8.8	7.3	5.7	8.3	7.8	5.1	4.6	8.0	6.1	30.0	5.6	14.0	3.0	6.0	5.4	13.2	15.1	14.4	19.7	12.3	12.0	13.4	13.8	17.1	14.6